Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Insmed reports phase I safety and PK data for treprostinil palmitil inhalation powder

Feb. 22, 2021

Orinove initiates phase Ib trial of oral ORIN-1001 in IPF

Feb. 19, 2021

Oneness submits IND in U.S. for phase II study of FB-704A in severe asthma

Feb. 19, 2021

New ENPP2 inhibitors identified at Boehringer Ingelheim

Feb. 18, 2021

Diffusion completes phase Ib study of TSC in hospitalized COVID-19 patients with hypoxemia

Feb. 17, 2021

Phase III trials of ziritaxestat in IPF discontinued

Feb. 11, 2021

NeuroRx reports preliminary phase IIb/III trial data on Zyesami in COVID-19 respiratory failure

Feb. 10, 2021

ImmunoMet Therapeutics set to begin phase I U.S. study of IM-156 in IPF

Feb. 9, 2021

In vivo data on IHL-675A supports expansion of indications to include COPD and asthma

Feb. 8, 2021

Phase II trial of ensifentrine pMDI formulation in COPD meets lung function endpoints

Feb. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...